Literature DB >> 12842272

Neuropeptide FF receptor 2 (NPFF2) is localized to pain-processing regions in the primate spinal cord and the lower level of the medulla oblongata.

Zhizhen Zeng1, Terrence P McDonald, Ruiping Wang, Qingyun Liu, Christopher P Austin.   

Abstract

Studies have suggested that NPFF-like peptides and their receptors play important roles in physiological and pathological conditions. Here, we show, using multiple expression modalities, that the type 2 NPFF receptor (hNPFF2) is expressed in regions of the primate spinal cord and brainstem mediating pain sensation. In situ hybridization using an NPFF2 riboprobe, and immunohistochemistry using a novel NPFF2 antibody, demonstrated strong NPFF2 expression in the superficial layer of the dorsal horn, and in the spinal trigeminal nucleus of the brainstem of the African green monkey (AGM). In addition, autoradiography using a radiolabeled NPFF analog ([125I]1DMe) revealed dense binding signal in the superficial layer of the dorsal horn in the spinal cord. The distribution pattern of hNPFF2 in the AGM spinal cord and the lower level of the brainstem are consistent with a hypothesized potential role for NPFF peptides in modulation of sensory input, opioid analgesia and morphine tolerance through spinal and supraspinal mechanisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842272     DOI: 10.1016/s0891-0618(03)00038-3

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  6 in total

1.  Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.

Authors:  K Elhabazi; J M Trigo; C Mollereau; L Moulédous; J-M Zajac; F Bihel; M Schmitt; J J Bourguignon; H Meziane; B Petit-demoulière; F Bockel; R Maldonado; F Simonin
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

2.  RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia.

Authors:  Frédéric Simonin; Martine Schmitt; Jean-Paul Laulin; Emilie Laboureyras; Jack H Jhamandas; David MacTavish; Audrey Matifas; Catherine Mollereau; Patrick Laurent; Marc Parmentier; Brigitte L Kieffer; Jean-Jacques Bourguignon; Guy Simonnet
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-03       Impact factor: 11.205

3.  Functional modulation of human delta opioid receptor by neuropeptide FF.

Authors:  Minna-Liisa Ankö; Pertti Panula
Journal:  BMC Neurosci       Date:  2005-04-04       Impact factor: 3.288

4.  Role of neuropeptide FF in central cardiovascular and neuroendocrine regulation.

Authors:  Jack H Jhamandas; Valeri Goncharuk
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-07       Impact factor: 5.555

5.  In Vitro Activities of Kissorphin, a Novel Hexapeptide KiSS-1 Derivative, in Neuronal Cells.

Authors:  Nathaniel G N Milton
Journal:  J Amino Acids       Date:  2012-07-09

6.  Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect.

Authors:  Flora Alexopoulou; Esben Matzen Bech; Søren Ljungberg Pedersen; Ditte Dencker Thorbek; Ulrike Leurs; Lise Christine Biehl Rudkjær; Keld Fosgerau; Henrik H Hansen; Niels Vrang; Jacob Jelsing; Lisbeth Elster
Journal:  Sci Rep       Date:  2022-02-01       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.